| Dear Voornaam, Welcome to your November newsletter. I hope you and your family are well. Over the past years and months, we've seen great determination, ground-breaking innovations and unfaltering resilience from across the research community. Everyone associated with Cancer Research UK (CRUK), from staff to donors, takes great pride in the incredible discoveries that our researchers make every year. It is great to be able to spotlight an example this month with recent Breakthrough Prize and Millennium Technology Prize winner, Shankar Balasubramanian, who tells us about his work on next generation sequencing and its profound impact on genomic research.
The early phase clinical trials team from Oxford University Hospitals were crowned winners of the RCN Nursing Awards’ 'Excellence in Cancer Research Nursing' category. They won for developing a wellbeing assessment for patients on early phase cancer trials. Congratulations to the Oxford team and indeed to all the finalists for their outstanding work in providing top quality care for cancer patients, which you can read about on our blog.
It is great to see the gradual return of face-to-face events. In February, we’re holding a one-day conference for research nurses and trial practitioners in Manchester, and on 16–18 May our Brain Tumour Conference returns in London, bringing together the brightest minds in brain tumour research and allied disciplines to explore the latest in this cancer of unmet need.
Kind regards, Iain Foulkes Executive Director, Research & Innovation Cancer Research UK |
|
|---|
|
|---|
|
|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
| | REMEMBERING DAVID LIVINGSTON We're deeply saddened by the recent news of David Livingston's death. A renowned scientist at the Dana-Farber Cancer Institute and a prominent figure in cancer research, his work has been the cornerstone of many studies on BRCA function and mutations and has paved the way for studying novel approaches to breast and ovarian cancer prevention. David was a long-term supporter of CRUK, from serving on the very first panel that reviewed our Centre funding, to most recently chairing our Accelerator Award Committee. |
|
|---|
|
|---|
|
|
Q&A WITH CATHERINE ELLIOTT, OUR NEW DIRECTOR OF RESEARCH Newly appointed director of research Dr Catherine Elliot has worked as a scientist, clinician and senior leader at some of the UK’s most prestigious research organisations. Her impressive scientific career spans veterinary medicine, gynaecology and obstetrics, neuroscience and mental health, medical law and ethics, experimental medicine and molecular pathology. We caught up with Catherine about the future of cancer research, recovering from the pandemic, research careers and the role of curiosity in a goal-driven scientific environment. |
|
|---|
| PROVIDING YOU THE SUPPORT FOR DEVELOPING YOUR RESEARCH CAREER CRUK is a proud signatory of the Researcher Development Concordat, which sets out obligations to improve the employment and support for researchers and their careers.
We've published an action plan to demonstrate our commitments as a funder in a transparent way and to emphasise the importance of our researchers and their development. |
|
|---|
|
|---|
|
|
| | WHAT THE SPENDING REVIEW MEANS FOR RESEARCH The recent Comprehensive Spending Review was broadly positive for medical research. With an increase in health research spending, further investment in R&D and support for international research – the mood music around the Budget has been good… but what does it mean for you? |
|
|---|
|
|---|
|
|
GET AN EARLY BIRD DISCOUNT FOR THE BRAIN TUMOUR CONFERENCE 2022 Registration for the CRUK Brain Tumour Conference is now open. Taking place on 16–18 May 2022 in London, our conference will bring together specialists in brain tumour research and allied disciplines for a jam-packed agenda of lightning talks, networking sessions and expert panel discussions. Our Scientific Committee is Michelle Monje (Stanford University), Richard Gilbertson (CRUK Cambridge Centre) and Simona Parrinello (UCL Cancer Institute). Information on the line-up of speakers will come soon. |
|
|---|
| THE EARLY DETECTION OF CANCER CONFERENCE 2022 – SAVE THE DATE Thank you to everyone who joined our Early Detection of Cancer Conference this year. We’re excited to confirm that the conference will return as an in-person event next year in Portland, Oregon. Join us on 18–20 October to discuss the latest in early detection research and meet experts from across the globe. Save the date and make sure you sign up to hear when registration opens. |
|
|---|
|
|---|
|
|
| | REGISTER FOR OUR UPCOMING EARLY DIAGNOSIS RESEARCH VIRTUAL SESSION Interested in learning more about inequalities in the early diagnosis of cancer? Join the 550 already registered for the next Early Diagnosis Research Virtual Session on Thursday 18 November. Speakers include: Professor Bernard Rachet, London School of Hygiene & Tropical Medicine Dr Katriina Whitaker, University of Surrey Chloe Thomas, University of Sheffield Professor Diana Sarfati, Cancer Control Agency, New Zealand Visit our virtual series webpage for more information. |
|
|---|
|
|---|
|
|
| | DEADLINE APPROACHING: PREVENTION AND POPULATION RESEARCH PROJECT AWARDS The deadline for our Prevention and Population Research Project Award is fast approaching. These awards provide support for research proposals centred on key questions in prevention and population research, including understanding the epidemiology of cancer, cancer risk, incidence and survival and preventative interventions. Successful applicants could receive up to £500k of funding for up to 3 years. |
|
|---|
|
|---|
|
|
HAVE YOUR SAY IN OUR CLINICAL CANCER RESEARCH WORKFORCE SURVEY If your work is connected to clinical cancer research, we want to hear from you. We want to better understand your experiences over the past 18 months (including the impact of COVID-19) and your plans for the future. The survey is open to anyone in clinical cancer research, including clinical staff (eg research nurses), non-clinical staff (eg pathologists), researchers (eg laboratory staff) and others. By taking part in this 5-10-minute survey, you'll help inform our work on science policy. |
|
|---|
| CATCH: NEW WEBSITE TO SUPPORT CLINICAL ACADEMIC CAREERS The Clinical Academic Training Forum has launched CATCH – the Clinical Academic Training & Careers Hub – a one-stop shop for information and resources to support clinical academics and clinicians considering a career in research. It’s a new initiative to help people at the start of their careers navigate the world of clinical academia. It has lots of practical advice on potential career options and building links between clinical practice and academia. |
|
|---|
|
|---|
|
|
| | FIND YOUR NEXT COLLABORATION THROUGH OUR OPEN LAB INITIATIVE Are you and your research group looking for new opportunities to exchange ideas and interact more closely with other groups? Our Open Lab Initiative is a digital platform that connects research groups with shared interests to spark discussion, stimulate fresh ideas and generate new collaborations. The initiative now has over 200 members and has matched over 100 research groups since 2020. Register today and within 5 working days we'll pair you with another group from across the UK. |
|
|---|
|
|---|
|
|
UPLOAD YOUR RESEARCH IN NCRI’S CANCER AND COVID-19 DASHBOARD NCRI has launched a dashboard of cancer and COVID-19 research which lists research projects looking at the impact of COVID-19 on cancer care and patients. Working together with us, the National Cancer Registration and Analysis Service (NCRAS) and the Cancer Alliance Data, Evaluation and Analysis Service (CADEAS), 89 studies have already been identified and uploaded to the dashboard. If you have studies in the area of cancer and COVID-19, we encourage you to take a look and upload your research. |
|
|---|
| A YEAR OF SCIENTIFIC CREATIVITY FOR CANCER GRAND CHALLENGES Cancer Grand Challenges is our ambitious partnership with the National Cancer Institute in the US. It dares diverse, global teams to come together, think differently and take on some of cancer's toughest challenges. Cancer Grand Challenges has launched its first annual progress magazine, ‘Discover: a year of scientific creativity’. The magazine celebrates the power of global collaboration and how its community of researchers continue to drive progress against cancer. |
|
|---|
|
|---|
|
|
| | | Register your interest 18 October 2022 |
|
|---|
|
|---|
|
|
| Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
